Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease (ACCTION)

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Pfizer

Information provided by (Responsible Party):

JANSSEN Alzheimer Immunotherapy Research & Development, LLC

ClinicalTrials.gov Identifier:

NCT01284387

First received: January 20, 2011

Last updated: January 17, 2012

Last verified: January 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	February 2014
Estimated Primary Completion Date:	January 2014 (Final data collection date for primary outcome measure)